Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Pathology, Research and Practice|June 22, 2024
Wnt/β-catenin-YAP axis in the pathogenesis of primary intraosseous carcinoma NOS, deriving from odontogenic keratocystYusuke Nakako, Kana Hasegawa, Shinsuke Fujii, et al.
IJU Case Reports|August 4, 2020
Refractory fistula of bladder repaired with transurethral cystoscopic injection of <i>N</i>-butyl-2-cyanoacrylateSakurako Mukai, Shunsuke Shinmei, Masayuki Muto, et al.
Pathology, Research and Practice|January 26, 2024
Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognosticationShinsuke Fujii, Kana Hasegawa, Takashi Maehara, et al.
Frontiers in Immunology|December 11, 2023
Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and <i>in vitro</i> experimentsHu Chen, Junsei Sameshima, Shiho Yokomizo, et al.
The Journal of Pathology|October 8, 2021
RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formationShinsuke Fujii, Takuma Ishibashi, Megumi Kokura, et al.
IJU Case Reports|August 4, 2020
Pneumatosis cystoides intestinalis linked to sunitinib treatment for renal cell carcinomaHiroyuki Shikuma, Shogo Inoue, Tomoya Hatayama, et al.
Pathology, Research and Practice|June 27, 2022
The Semaphorin 3A-AKT axis-mediated cell proliferation in salivary gland morphogenesis and adenoid cystic carcinoma pathogenesisShinsuke Fujii, Tatsufumi Fujimoto, Kana Hasegawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2019
Clinical staging of upper urinary tract urothelial carcinoma for T staging: Review and pictorial essayYukiko Honda, Yuko Nakamura, Jun Teishima, et al.
International Cancer Conference Journal|June 1, 2019
Serous adenocarcinoma of retroperitoneum: a case reportYuki Kohada, Jun Teishima, Yui Hattori, et al.
Molecular Cancer Therapeutics|January 17, 2019
Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor GrowthTakeshi Harada, Shinji Matsumoto, Suguru Hirota, et al.
Pageof 8